Ultrasound imaging technology developer Targeson said that its optical imaging grant program will receive funding from the U.S. National Institutes of Health (NIH).
The Small Business Innovation Research (SBIR) grant will explore the use of Targeson's microbubble platform as a targeted contrast agent using optical imaging, according to the San Diego-based firm.
Related Reading
Targeson moves to San Diego, December 16, 2009
Targeson launches US contrast agent, August 26, 2009
Targeson debuts US contrast agent, August 11, 2009
Copyright © 2010 AuntMinnie.com